+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Exemestane"

From
From
AFINITOR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AFINITOR Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Research Report on China's Exemestane Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Exemestane Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Exemestane is a type of drug used to treat lung cancer. It is a type of aromatase inhibitor, which works by blocking the production of estrogen in the body. This helps to reduce the growth of certain types of cancer cells that need estrogen to grow. Exemestane is used to treat postmenopausal women with hormone receptor-positive breast cancer. It is also used to reduce the risk of breast cancer in postmenopausal women who have a high risk of developing the disease. Exemestane is available in tablet form and is taken orally once a day. It is usually taken for five years or until the cancer has been treated. Common side effects of exemestane include hot flashes, joint pain, fatigue, nausea, and vomiting. Exemestane is a widely used drug in the treatment of lung cancer. It is an important part of the treatment regimen for many patients, and is often used in combination with other drugs. Some companies that produce exemestane include Pfizer, Novartis, and AstraZeneca. Show Less Read more